Bone Marrow Aspirate Concentrate for Anterior Cruciate Ligament Tear Treatment.
Using Autologous Bone Marrow Aspirate Concentrate to Treat Complete Anterior Cruciate Ligament Tear.
abdulmajeed hammadi
20 participants
Apr 2, 2024
INTERVENTIONAL
Summary
A single armed multicenter study enrolling 20 patients using autologous bone marrow aspirate concentrate (which is done under local or general anesthesia to aspirate around 1-2 cc/kg body weight then concentration which is done by using centrifugation and special disposable kit) local injection of 4 cc per joint under ultrasonic guidance ,completely sterile field with local anesthesia.
Eligibility
Inclusion Criteria2
- - Confirmed diagnosis of complete or partial ACL tear via clinical examination and imaging studies.
- \. Aged between 20 and 55 years, to encompass the typical age range of patients with sports-related ACL injuries.
Exclusion Criteria3
- - Patients with a history of bleeding disorders, as this could complicate the aspiration and injection procedures.
- \. Individuals with a history of malignancy, due to the potential risks associated with growth factors present in BMAC.
- \. Critically ill patients or those with comorbidities
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
local knee joint injection of autologous bone marrow
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06353503